Hematological Malignancy Patients, COVID-19, and Favipiravir

被引：0
|
作者：
Mungmunpuntipantip, Rujittika [1 ]
Wiwanitkit, Viroj [1 ]
机构：
[1] DY Patil Univ, Pune, Maharashtra, India
来源：
TURKISH JOURNAL OF HEMATOLOGY | 2021年 / 38卷 / 04期
关键词：
Malignancy; COVID-19; Favipirav;
D O I：
10.4274/tjh.galenos.2021.2021.0582
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：331 / 332
页数：2
相关论文
共 50 条
  • [1] The effects of favipiravir on hematological parameters of covid-19 patients
    Yaylaci, Selcuk
    Dheir, Hamad
    Senocak, Didar
    Genc, Ahmed Bilal
    Kocayigit, Havva
    Cekic, Deniz
    Varim, Ceyhun
    Aydin, Abdulkadir
    Koroglu, Mehmet
    Karabay, Oguz
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2020, 66 : 65 - 70
  • [2] The outcome of COVID-19 in patients with hematological malignancy
    Yigenoglu, Tugce N.
    Ata, Naim
    Altuntas, Fevzi
    Basci, Semih
    Dal, Mehmet Sinan
    Korkmaz, Serdal
    Namdaroglu, Sinem
    Basturk, Abdulkadir
    Hacibekiroglu, Tuba
    Dogu, Mehmet H.
    Dal, Kursat
    Erkurt, Mehmet A.
    Turgut, Burhan
    Ulgu, Mustafa Mahir
    Celik, Osman
    Imrat, Ersan
    Birinci, Suayip
    JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (02) : 1099 - 1104
  • [3] The outcome of COVID-19 in patients with hematological malignancy
    Pınar Tığlıoğlu
    Murat Albayrak
    Mesut Tığlıoğlu
    Hacer Berna Afacan Öztürk
    Merih Reis Aras
    Buğra Sağlam
    Senem Maral
    memo - Magazine of European Medical Oncology, 2022, 15 : 83 - 89
  • [4] The outcome of COVID-19 in patients with hematological malignancy
    Tiglioglu, Pinar
    Albayrak, Murat
    Tiglioglu, Mesut
    Ozturk, Hacer Berna Afacan
    Aras, Merih Reis
    Saglam, Bugra
    Maral, Senem
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2022, 15 (01) : 83 - 89
  • [5] The outcome of COVID-19 in patients with hematological malignancy
    Yigenoglu, Tugce N.
    Basci, Semih
    Dal, Mehmet S.
    Korkmaz, Serdal
    Turgut, Burhan
    Altuntas, Fevzi
    JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (03) : 1255 - 1255
  • [6] Evaluation of the effect of favipiravir on patients with COVID-19
    Kamali, Alireza
    Sarmadian, Hossein
    Mahmoodiyeh, Behnam
    Valibeik, Shamim
    Farmani, Farzane
    Bashirgonbadi, Zahra
    JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE, 2023, 12 (02) : 242 - 245
  • [7] Pharmacokinetic characterization of favipiravir in patients with COVID-19
    Gulhan, Rezzan
    Eryuksel, Emel
    Oglu, Medine Gulcebi Idriz
    Culpan, Yekta
    Toplu, Aylin
    Kocakaya, Derya
    Tigen, Elif
    Sengel, Buket Erturk
    Sili, Uluhan
    Yildizeli, Sehnaz Olgun
    Balcan, Mehmet Baran
    Elci, Abdullah
    Bulut, Cenk
    Karaalp, Atila
    Yananli, Hasan Raci
    Guner, Abdullah Emre
    Hatipoglu, Mustafa
    Karakurt, Sait
    Korten, Volkan
    Ratnaraj, Neville
    Patsalos, Philip
    Ay, Pinar
    Onat, Filiz
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 88 (07) : 3516 - 3522
  • [8] The effects of favipiravir on hematological parameters of covid-19 patients (vol 66, pg 65, 2020)
    Ferreira Silva, Dayane Helen
    de Camargos, Julia Hinkelmann
    Rodrigues, Jefferson Guimaraes
    Nogueira, Leilismara Sousa
    de Azevedo, Denia Alves
    Carvalho, Maria das Gracas
    Pinheiro, Melina de Barros
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2020, 66 (10): : 1463 - 1463
  • [9] Population pharmacokinetics of favipiravir in patients with COVID-19
    Irie, Kei
    Nakagawa, Atsushi
    Fujita, Hirotoshi
    Tamura, Ryo
    Eto, Masaaki
    Ikesue, Hiroaki
    Muroi, Nobuyuki
    Fukushima, Shoji
    Tomii, Keisuke
    Hashida, Tohru
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2021, 10 (10): : 1161 - 1170
  • [10] Favipiravir for treating COVID-19
    Korula, Pritish
    Alexander, Hanna
    John, Jisha Sara
    Kirubakaran, Richard
    Singh, Bhagteshwar
    Tharyan, Prathap
    Rupali, Priscilla
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2024, (02):
12345